Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29351143 | 1.00 | DRD1 (1.00) | DRD1CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL29359136 | 1.00 | DRD1 (1.00) | DRD1CYP3A4TDP1ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL29821183 | 0.98 | DRD1 (0.97) | DRD1CYP3A4TDP1 | |
| Ammonia Solution, Strong SCHEMBL19127610 | 0.98 | DRD1 (0.97) | DRD1CYP3A4TDP1 | |
| Hydrochloric Acid SCHEMBL28990395 | 0.98 | DRD1 (0.97) | DRD1CYP3A4TDP1 | |
| SCHEMBL25373924 | 0.98 | DRD1 (0.97) | DRD1CYP3A4TDP1 | |
| SCHEMBL17743663 | 0.98 | DRD1 (0.97) | DRD1CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL15209802 | 0.98 | DRD1 (0.97) | DRD1CYP3A4TDP1 | |
| SCHEMBL38656170 | 0.98 | DRD1 (0.97) | DRD1CYP3A4TDP1 | |
| Phosphine SCHEMBL28527853 | 0.98 | DRD1 (0.97) | DRD1CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 22364 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637412-B2 | Preparation of aromatic carboxyamides by a palladium-catalyzed carbonylation reaction | BASF SE (DE) | 2026-05-26 | — | — | US | claimed |
| US-12606566-B2 | Substituted cyclopenta[4,5]pyrrolo[1,2-a]pyrazines as bruton's tyrosine kinase inhibitors | SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD. (CN) | 2026-04-21 | — | — | US | claimed |
| EP-4725945-A1 | PREPARATION METHOD FOR FORMAMIDE COMPOUNDS | Shanghai Senhui Medicine Co., Ltd. (CN) | 2026-04-15 | — | — | EP | claimed |
| US-20260098048-A1 | IMPROVED PROCESS FOR THE PREPARATION OF RISDIPLAM AND ITS INTERMEDIATES | NATCO PHARMA LTD (IN) | 2026-04-09 | — | — | US | claimed |
| US-12577236-B2 | Processes for preparation of Tezacaftor | LAURUS LABS LIMITED (IN) | 2026-03-17 | — | — | US | claimed |
| US-20260062361-A1 | PROCESS FOR THE PREPARATION OF BIO-BASED OLEFINS FROM PRIMARY ALCOHOL | BASF SE (DE) | 2026-03-05 | — | — | US | claimed |
| EP-3950682-B1 | PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD | SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN) | 2026-02-11 | — | — | EP | claimed |
| EP-4688717-A1 | PALLADIUM-CATALYZED CHEMOSELECTIVE MONO-ALPHA-ARYLATION OF O-PROTECTED HYDROXYACETONE | Bayer Aktiengesellschaft (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4471011-B1 | PROCESS FOR THE SELECTIVE CLEAVAGE OF C-SCF3 BONDS AND ANALOGUES | CENTRE NAT RECH SCIENT (FR) | 2026-01-14 | — | — | EP | claimed |
| EP-4294783-B1 | HYDROGENATION OF DIENALS OR DIENONES WITH RHODIUM COMPLEXES UNDER CARBON MONOXIDE FREE ATMOSPHERE | FIRMENICH & CIE (CH) | 2025-10-15 | — | — | EP | claimed |
| WO-2007025693-A1 | PROCESS FOR THE PRODUCTION OF ANILINES | SYNGENTA PARTICIPATIONS AG (CH) | 2007-03-08 | — | — | WO | claimed |
| EP-1716140-A1 | COUPLING REACTIONS USEFUL IN THE PREPARATION OF (1H-TETRAZOL-5-YL)-BIPHENYL DERIVATIVES | Novartis AG (CH) | 2006-11-02 | — | — | EP | claimed |
| EP-1636160-A4 | NOVEL THERAPEAUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLIC DISEASES AND SKIN DISORDERS | AUSPEX PHARMACEUTICALS (US) | 2006-09-27 | — | — | EP | claimed |
| WO-2006079819-A2 | IMPROVED METHOD FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED SECONDARY ALCOHOLS BY THE ADDITION OF ORGANOALUMINIUM REAGENTS TO CARBONYL COMPOUNDS | UNIVERSITY OF NOTTINGHAM (GB) | 2006-08-03 | — | — | WO | claimed |
| EP-1636160-A2 | NOVEL THERAPEAUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLIC DISEASES AND SKIN DISORDERS | Auspex Pharmaceuticals (US) | 2006-03-22 | — | — | EP | claimed |
| EP-1622861-A1 | METHOD OF FORMING A CARBON-HETEROATOM BOND | RHODIA CHIMIE (FR) | 2006-02-08 | — | — | EP | claimed |
| WO-2005108338-A1 | NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLIC DISEASES AND SKIN DISORDERS | AUSPEX PHARMACEUTICALS (US) | 2005-11-17 | — | — | WO | claimed |
| WO-2005075462-A1 | COUPLING REACTIONS USEFUL IN THE PREPARATION OF (1H-TETRAZOL-5-YL)-BIPHENYL DERIVATIVES | NOVARTIS AG (CH) | 2005-08-18 | — | — | WO | claimed |
| WO-2005000233-A2 | NOVEL THERAPEAUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLIC DISEASES AND SKIN DISORDERS | AUSPEX PHARMACEUTICALS (US) | 2005-01-06 | — | — | WO | claimed |
| WO-2004101496-A1 | METHOD OF FORMING A CARBON-HETEROATOM BOND | RHODIA CHIMIE (FR) | 2004-11-25 | — | — | WO | claimed |